Akeega
Safety Classified by Officially
Akeega Active substance Niraparib and abiraterone acetate Holder Janssen-Cilag NV Status Running Indication with prednisone or prednisolone and in combination with androgen deprivation therapy (ADT) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer (mHSPC) and BRCA 1/2 mutations, (germline and/or somatic) Public documents Approbation Information for the …
This is an extract. The publication continues at the source.
Read the original at the source: https://www.famhp.be/nl/menselijk_gebruik/geneesmiddelen/geneesmiddelen/onderzoek_ontwikkeling/gebruik_in_schrijnende_278
Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
- Official source
- https://www.famhp.be/en/rss.xml RSS
- Imported
- October 21, 2026 06:32
- Versions
- 1 recorded
- Identity
-
110428 at https://www.famhp.be